Patents by Inventor Hee Chung Kwon

Hee Chung Kwon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer-treating pharmaceutical composition inhibiting expression of CCND3 or PAK2 gene
    Patent number: 10760082
    Abstract: A substance inhibiting the expression of CCND3 gene or PAK2 gene, the substance containing a nucleotide such as miR-4779, may be efficiently used for preventing or treating cancer. In addition, by screening the substance that inhibits the expression of CCND3 gene or PAK2 gene, a candidate substance for preventing or treating cancer may be selected.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: September 1, 2020
    Assignee: Korea Institute of Radiological & Medical Sciences
    Inventors: Kyung Hee Koo, Hee Chung Kwon, Jie Young Song
  • CANCER-TREATING PHARMACEUTICAL COMPOSITION INHIBITING EXPRESSION OF CCND3 OR PAK2 GENE
    Publication number: 20190256857
    Abstract: A substance inhibiting the expression of CCND3 gene or PAK2 gene, the substance containing a nucleotide such as miR-4779, may be efficiently used for preventing or treating cancer. In addition, by screening the substance that inhibits the expression of CCND3 gene or PAK2 gene, a candidate substance for preventing or treating cancer may be selected.
    Type: Application
    Filed: December 21, 2017
    Publication date: August 22, 2019
    Applicant: KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
    Inventors: Kyung Hee Koo, Hee Chung Kwon, Jie Young Song
  • Composition comprising miRNA for enhancing radiation sensitivity
    Patent number: 9175288
    Abstract: Provided are a method of enhancing radiation sensitivity by using miR-499b-5p and a method of treating a radiation resistant cancer including administering miR-499b-5p.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: November 3, 2015
    Assignee: Korea Institute of Radiological & Medical Sciences
    Inventors: Hee Chung Kwon, Eun Sook Kim, Jie Young Song
  • COMPOSITION COMPRISING miRNA FOR ENHANCING RADIATION SENSITIVITY
    Publication number: 20150141486
    Abstract: Provided are a method of enhancing radiation sensitivity by using miR-499b-5p and a method of treating a radiation resistant cancer including administering miR-499b-5p.
    Type: Application
    Filed: April 29, 2014
    Publication date: May 21, 2015
    Applicant: KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
    Inventors: Hee Chung KWON, Eun Sook KIM, Jie Young SONG
  • Pharmaceutical composition for treating malignant tumors containing human p31 genes
    Patent number: 8354386
    Abstract: A pharmaceutical composition for the treatment of malignant tumors comprising a human p31comet gene encoding protein represented by SEQ ID NO: 3 or 4 as an effective component is provided. The pharmaceutical composition can suppress cancer cell growth, induce apoptosis and kill cells by overexpressing p31comet in the solid malignant tumor cells. Therefore, the pharmaceutical composition can be effectively used for gene therapy.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: January 15, 2013
    Assignee: Korea Institute of Radiological & Medical Sciences
    Inventors: Kee-Ho Lee, Sang-Hoon Kim, Hyun-Jung Baek, Kyoung-Mi Juhn, Jae-Min Jeong, Yeun-Jin Ju, Bu-Yeo Kim, Eun-Ju Lee, Yong-Ho Ham, Hee-Chung Kwon, Mi-Yong Yun, Gil-Hong Park
  • Protein increasing cell infectivity of herpes simplex virus and use thereof
    Patent number: 8318662
    Abstract: Provided are an isolated protein derived from an N-terminal of HveA/HVEM and having activity of increasing the cell infectivity of herpes simplex virus (HSV) and use thereof.
    Type: Grant
    Filed: March 16, 2009
    Date of Patent: November 27, 2012
    Assignee: Korea Institute of Radiological & Medical Sciences
    Inventors: Hee Chung Kwon, Hyun Jung Baek, Kee Ho Lee, Masahide Kuroki
  • PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT TUMORS CONTAINING HUMAN p31 GENES
    Publication number: 20100292166
    Abstract: A pharmaceutical composition for the treatment of malignant tumors comprising a human p31comet gene encoding protein represented by SEQ ID NO: 3 or 4 as an effective component is provided. The pharmaceutical composition can suppress cancer cell growth, induce apoptosis and kill cells by overexpressing p31comet in the solid malignant tumor cells. Therefore, the pharmaceutical composition can be effectively used for gene therapy.
    Type: Application
    Filed: December 20, 2005
    Publication date: November 18, 2010
    Applicant: KOREA ATOMIC ENERGY RESEARCH INSTITUTE
    Inventors: Kee-Ho Lee, Sang-Hoon Kim, Hyun-Jung Baek, Kyoung-Mi Juhn, Jae-Min Jeong, Yeun-Jin Ju, Bu-Yeo Kim, Eun-Ju Lee, Yong-Ho Ham, Hee-Chung Kwon, Mi-Yong Yun, Gil-Hong Park
  • Protein increasing cell infectivity of herpes simplex virus and use thereof
    Publication number: 20100233758
    Abstract: Provided are an isolated protein derived from an N-terminal of HveA/HVEM and having activity of increasing the cell infectivity of herpes simplex virus (HSV) and use thereof.
    Type: Application
    Filed: March 16, 2009
    Publication date: September 16, 2010
    Applicant: KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES
    Inventors: Hee Chung Kwon, Hyun Jung Baek, Kee Ho Lee, Masahide Kuroki